-
公开(公告)号:US20190188546A1
公开(公告)日:2019-06-20
申请号:US16011509
申请日:2018-06-18
Inventor: Roozbeh Tabrizian , Swarup Bhunia
IPC: G06K19/04 , G06K1/12 , H01L41/09 , H01L41/314 , H01L41/187
Abstract: Data is encoded for identification and labeling using a multitude of nano-electro-mechanical structures formed on a substrate. The number of such structures, their shapes, choice of materials, the spacing therebetween and the overall distribution of the structures result in a vibrational pattern or an acoustic signature that uniquely corresponds to the encoded data. A first group of the structures is formed in conformity with the design rules of a fabrication process used to manufacture the device that includes the structures. A second group of the structures is formed so as not to conform to the design rules and thereby to undergo variability as a result of the statistical variations that is inherent in the fabrication process.
-
公开(公告)号:US10314893B2
公开(公告)日:2019-06-11
申请号:US15030377
申请日:2016-04-18
Applicant: The Trustees of the University of Pennsylvania , University of Florida Research Foundation, Inc.
Inventor: Henry Daniell , Qiuhong Li , Mohan K. Raizada
IPC: A61K38/48 , A61K9/19 , A61K9/00 , A61K38/22 , A61K9/16 , A61K9/50 , C12N9/48 , C12N15/82 , A61K38/16 , A61K36/23 , A61K36/28 , A61K36/31 , C07K14/28 , A61K47/65 , A61K47/64
Abstract: Emerging evidence indicates that diminished activity of the vasoprotective axis of the renin-angiotensin system, constituting angiotensin converting enzyme2 (ACE2) and its enzymatic product, angiotensin-(1-7) [Ang-(1-7)] contribute to pulmonary hypertension (PH). However, clinical success for long-term delivery of ACE2 or Ang-(1-7) would require stability and ease of administration to increase patient compliance. Chloroplast expression of therapeutic proteins enables their bioencapsulation within plant cells to protect from acids and gastric enzymes; fusion to a transmucosal carrier facilitates effective systemic absorption. Oral feeding of rats with bioencapsulated ACE2 or Ang-(1-7) attenuated monocrotaline (MCT)-induced increase in right ventricular systolic pressure, decreased pulmonary vessel wall thickness and improved right heart function in both prevention and reversal protocols. Furthermore, combination of ACE2 and Ang-(1-7) augmented the beneficial effects against cardio-pulmonary pathophysiology induced by MCT administration.Experiments have also been performed which indicate that this approach is also suitable for the treatment or inhibition of experimental uveitis and autoimmune uveoretinitis These studies provide proof-of-concept for a novel low-cost oral ACE2 or Ang-(1-7) delivery system using transplastomic technology for pulmonary and ocular disease therapeutics.
-
公开(公告)号:US20190170738A1
公开(公告)日:2019-06-06
申请号:US16206493
申请日:2018-11-30
Inventor: Fan Ren , Stephen J. Pearton
IPC: G01N33/543 , G01N33/68 , H01L29/20 , H01L29/778
Abstract: Various examples are provided for low cost disposable medical sensors fabricated on glass, paper or plastics, and applications thereof. In one example, a medical sensor includes a base structure comprising a functionalized sensing area; and a transistor disposed on the base structure adjacent to the functionalized sensing area. In another example, a medical sensor includes a base structure comprising a functionalized sensing area disposed on a first electrode pad and a reference sensing area disposed on a second electrode pad separated from the first electrode pad; and a transistor having a gate electrically coupled to the second electrode pad of the base structure. A gate pulse applied to the functionalized sensing can produce a drain current corresponding to an amount of a target present in a sample disposed on the base structure.
-
公开(公告)号:US10308957B2
公开(公告)日:2019-06-04
申请号:US15123515
申请日:2015-03-04
Inventor: Shannon E. Boye , Sanford L. Boye , Mavis Agbandje-McKenna , Arun Srivastava
IPC: C12N15/86 , C07K14/005 , A61K48/00 , A61K9/00 , A61K9/51
Abstract: Disclosed are capsid-modified rAAV particles and expression vectors, as well as compositions and pharmaceutical formulations that comprise them. Also disclosed are methods of preparing and using novel capsid-protein-mutated particle or rAAV vector constructs in a variety of diagnostic and therapeutic applications including, inter alia, as delivery agents for diagnosis, treatment, or amelioration of one or more diseases, disorders, or dysfunctions of the mammalian eye. Also disclosed are methods for subretinal delivery of therapeutic gene constructs to mammalian photoreceptors and retinal pigment epithelial cells, as well as use of the disclosed compositions in the manufacture of medicaments for a variety of in vitro and/or in vivo applications including the treatment of a variety of inherited retinal diseases.
-
185.
公开(公告)号:US20190165935A1
公开(公告)日:2019-05-30
申请号:US16309397
申请日:2017-06-14
Inventor: Mark M. Tehranipoor , Domenic J. Forte , Ujjwal Guin
Abstract: Methods and integrated circuit architectures for assuring the protection of intellectual property between third party IP providers, system designers (e.g., SoC designers), fabrication entities, and assembly entities are provided. Novel design flows for the prevention of IP overuse, IP piracy, and IC overproduction are also provided. A comprehensive framework for forward trust between 3PIP vendors, SoC design houses, fabrication entities, and assembly entities can be achieved, and the unwanted modification of IP can be prevented.
-
公开(公告)号:US20190144611A1
公开(公告)日:2019-05-16
申请号:US16304433
申请日:2017-05-26
Inventor: Kenneth B. WAGENER , Taylor W. GAINES , Michael BELL
IPC: C08G75/20 , C08J3/24 , H01M8/1032 , H01M8/1027 , B01D71/68
Abstract: A polysulfone has sulfone units that are separated by alkylene units in a polymer chain or a copolymer chain where the alkylene units have at least four carbons between sulfone units. The alkylene units can include an ethenylene unit separated from the sulfone units by at least one methylene units. The polysulfones can be crosslinked for enhanced thermal stability. Membranes can be formed from the polysulfones.
-
公开(公告)号:US20190142003A1
公开(公告)日:2019-05-16
申请号:US16097934
申请日:2017-05-25
Applicant: Philip G. KOEHLER , Roberto M. PERERIA , Christopher D. BATICH , University of Florida Research Foundation, Inc.
Inventor: Philip G. Koehler , Roberto M. Pereira , Christopher D. Batich
Abstract: Compositions, formulas, methods of making, mixing and applying insecticide formulations to different surfaces such as but not limited to interior surfaces of ovitraps, on walls and on chips and tiles to produce a texturized surface to allow for better transfer of the insecticidal active ingredients to insects, such as mosquitoes and the like, which land on or crawl on the surfaces, resulting in faster insect mortality rates. The texture of the insecticidal residue provides better transfer of the insecticidal active ingredients to insects that land on or crawl on the surface, resulting in faster insect mortality. The textured residue also enhances desirable surface characteristics for landing of mosquitoes and potentially other insects.
-
公开(公告)号:US10287239B1
公开(公告)日:2019-05-14
申请号:US15981833
申请日:2018-05-16
Inventor: Alexander James Grenning , Sarah Scott
IPC: C07C253/30 , C07C255/31 , C07C255/47 , C07D227/04
Abstract: In one aspect, the disclosure relates to methods for preparation of intermediates useful for the preparation of terpenoid cores. In a further aspect, the disclosed methods pertain to the preparation of compounds comprising a terpenoid core or scaffold, such as 6/7/5 tricycloalkanes. The disclosed methods utilize abundant starting materials and simple reaction sequences that can be used to tunably and scalably assemble common terpenoid cores. In various aspects, the present disclosure pertains to compounds prepared using the disclosed methods. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.
-
公开(公告)号:US20190136084A1
公开(公告)日:2019-05-09
申请号:US16096873
申请日:2017-04-11
Inventor: Wolfgang M. SIGMUND , Yung-Chieh HUNG
IPC: C09D127/16 , C09D7/62 , C09D7/63 , C09D7/40 , C09D7/20 , C08K3/22 , C08K3/36 , C08K9/06 , C08K5/1535 , C08K5/521
CPC classification number: C09D127/16 , B05D5/06 , B05D5/083 , C08K3/22 , C08K3/36 , C08K5/1535 , C08K5/521 , C08K9/06 , C08K2003/2227 , C08K2003/2241 , C08K2201/005 , C08L33/12 , C09D5/00 , C09D5/29 , C09D7/20 , C09D7/40 , C09D7/62 , C09D7/63 , C09D7/67 , C09D7/68 , C09D7/69 , C09D133/12 , C08K5/52
Abstract: A colored paint that imparts a superhydrophobic surface on an object is a suspension of hydrophobic particles in a polymeric binder and a plasticizer in a solvent or mixed solvent, wherein at least a portion of the hydrophobic particles are colored particles. Colored particles can be ultramarine, iron oxide, chromium oxide, or any other colored metal oxide. The hydrophobic particles can be metal oxide particles that are surface functionalized with a fluorinated alkyl silane or an alkyl silane. The binder is a mixture of PDVF and PMMA in a ratio of 3:1 to 10:1. The plasticizer is a mixture of triethyl phosphate and perfluoro(butyltetrahydrofuran) or other perfluorinated hydrocarbon. Surfaces coated using this paint display contact angles in excess of 150° and resist abrasion.
-
公开(公告)号:US20190126288A1
公开(公告)日:2019-05-02
申请号:US16094050
申请日:2017-05-12
Inventor: Jon P. Dobson , Isaac Ernest Philip Finger-Baker
Abstract: Embodiments of the present disclosure include separating devices and systems and methods of use. Embodiments of the present disclosure include separation devices including magnetic arrays and sheet-flow separation chambers. In an embodiment, the separating device enables the generation of multiple, and in some configurations, intersecting, high gradient magnetic field lines, resulting in strong separation forces, which permits for scale up to large areas and/or volumes (e.g., extracorporeal blood filtration system).
-
-
-
-
-
-
-
-
-